These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10471109)

  • 1. Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study.
    Gold J; Batterham M
    Int J STD AIDS; 1999 Aug; 10(8):558. PubMed ID: 10471109
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C; Macía ML; García J; Navarro JF
    Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
    Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
    Saha B; Rajadhyaksha GC; Ray SK
    J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 9. Histological assessment of ovaries and uterus of rats subjected to nandrolone decanoate treatment.
    Gerez JR; Frei F; Camargo IC
    Contraception; 2005 Jul; 72(1):77-80. PubMed ID: 15964297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
    Gerritsma EJ; Brocaar MP; Hakkesteegt MM; Birkenhäger JC
    Clin Otolaryngol Allied Sci; 1994 Feb; 19(1):79-84. PubMed ID: 8174308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An acute myocardial infarction occurring in an anabolic steroid user.
    Huie MJ
    Med Sci Sports Exerc; 1994 Apr; 26(4):408-13. PubMed ID: 8201894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
    Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
    AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of nandrolone decanoate on the central nervous system.
    Busardò FP; Frati P; Sanzo MD; Napoletano S; Pinchi E; Zaami S; Fineschi V
    Curr Neuropharmacol; 2015 Jan; 13(1):122-31. PubMed ID: 26074747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
    Cuerda C; Zugasti A; Bretón I; Camblor M; Miralles P; García P
    Nutr Clin Pract; 2005 Feb; 20(1):93-7. PubMed ID: 16207650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
    Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
    J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies.
    Schroeder ET; Terk M; Sattler FR
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E16-24. PubMed ID: 12637255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M; Saraf ML
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract]   [Full Text] [Related]  

  • 18. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C; Riis BJ; Pødenphant J; Christiansen C
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic, supra-physiological doses of nandrolone decanoate and exercise induced cardio-toxicity in an animal-model study.
    Fineschi V
    Acta Physiol (Oxf); 2013 Jun; 208(2):141-3. PubMed ID: 23480556
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nandrolone decanoate administered to patients with Gynaecomastia (author's transl)].
    Heresová J; Hampl R; Kuska L; Stárka L
    Cas Lek Cesk; 1981; 120(52):1602-5. PubMed ID: 7326723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.